Try HoloMonitor from a distance —
book your free live cell demo
!
Home
/
Investor Relati…
/
News
About
Our Story
To understand and cure the diseases that still plague humanity, medical science needs new tools.
Our Story
Background
Management and Board
Career
Partnerships
National Institute on Aging
Northeastern University
Huntsman Cancer Institute
UCSF
Gladstone Institutes
Lund University Cancer Centre
Malmö University
Uppsala University
Products
HoloMonitor
The HoloMonitor cell culture microscope non-invasively analyses cellular response and dynamic behavior in an …
HoloMonitor
Cell Imaging System
System Components
App Suite Cell Imaging Software
HoloLids
Technology
Gentle Live Cell Imaging
Quantitative Phase Imaging
Holographic Microscopy
Time-lapse Imaging Cytometry
Applications
Overview
Explore our range of live cell imaging applications and assays, circumventing the drawbacks of traditional …
Overview
Single-Cell Analysis
Cell QC
Cell Counter
Cell Proliferation
Cell Migration
Cell Motility and Migration
Cell Motility
Wound Healing
Dose Response
Cell Morphology
Cell Tracking
Publications
News
News and press releases.
News
Peer Reviewed Publications
Conference Papers and Posters
Doctoral Thesis
Resources
Webinars
We are happy to invite you to our series of live cell imaging webinars! Welcome to attend live, or view on demand …
Cell Videos & Tutorials
Brochures & Flyers
Application Notes
Manuals & Protocols
Webinars
Users
Blog
The Cell Cycle
Investor Relations
CEO Commentaries
CEO Peter Egelberg's blog, commenting PHI and medical science in general.
Introduktion
Bolagspresentation
Videopresentationer
CEO Commentaries
IR Contact
Stock Information
Reports & Documents
Investor Calendar
News
Contact
Book a Live Cell Imaging Demo
Book your live cell imaging demo of the incubator-based HoloMonitor cell culture microscope.
Contact PHI
Distributors
Contact IR
Book a Live Cell Imaging Demo
Shop
Webshop
Shop HoloMonitor products, applications and download the App Suite software.
Webshop
Cart
Checkout
My Account
Terms and Conditions
News
In English
March 31, 2020
New CEO commentary: “Bridging Corona”
As the dust from the stampede of bewildered politicians and overconfident billionaires settles, we begin to discern the new world shaped by the COVID-19 pandemic.
March 12, 2020
Interim Report 3 2019/20
With permanent staff on the ground in the US, we will be able to prepare, train and support a US sales organization much more efficiently than what was previously achievable.
March 10, 2020
Gladstone Institutes, University of California and PHI form joint Center of Excellence
Gladstone Institutes, University of California in San Francisco and PHI recently formed San Francisco’s Center of Excellence for Holographic Imaging Cytometry.
March 2, 2020
New CEO commentary: “Joining forces with Huntsman”
PHI recently joined forces with the Huntsman Cancer Institute in the battle against cancer.
January 7, 2020
CEO interview in BioStock
In the article published today by BioStock, the company's CEO Peter Egelberg comments on the developments during the past autumn.
January 2, 2020
New CEO commentary: “The Single-Cell Revolution”
PHI’s CEO and founder Peter Egelberg comments the recently published innovation report from the UN agency World Intellectual Property Organization.
1
2
3
4
…
13
In Swedish
May 23, 2019
Idag inleds inlösenperioden av teckningsoptioner av serie TO 2
Idag, den 23 maj 2019, inleds inlösenperioden av de teckningsoptioner av serie TO 2 som emitterades i samband med Phase Holographic Imaging PHI AB:s (”PHI”) företrädesemission av units under sommaren 2018.
December 6, 2018
Lunds Universitet och PHI samarbetar kring utveckling av nya 3D-cellodlingsmetoder för immunterapiforskning
Baserat på PHI:s befintliga HoloMonitor-teknik, har institutionen för Immunteknologi vid Lunds Universitet och Phase Holographic Imaging (PHI) avtalat om att gemensamt utveckla nya metoder för 3‑dimensionell cellodling. Detta för att möta ett akut och snabbt växande behov av dessa metoder inom cancerforskningen.
March 20, 2017
PHI and Malmö University receives 2.3 million SEK to detect blood-borne cancer cells
GlycoImaging is a collaboration project between PHI, Malmö University and four international research institutions. By combining PHI’s HoloMonitor technology with a new type of cancer probes, more sensitive methods to detect and diagnose cancer at an earlier stage than what is possible today.
1
2
3
Latest CEO Commentaries
August 26, 2020
Probably, the fastest website in the world
The page you now are reading probably appeared faster on your screen than any other web page you have read.
March 31, 2020
Bridging Corona
As the dust from the stampede of bewildered politicians and overconfident billionaires settles, we begin to discern the new world shaped by the COVID-19 pandemic.
March 2, 2020
Joining forces with Huntsman
PHI recently joined forces with the Huntsman Cancer Institute in the battle against cancer. Using PHI's HoloMonitor technology, the researchers at Huntsman aim to develop methods quantifying the phenomena known as epithelial–mesenchymal transition (EMT).
View all commentaries